Collegium Pharmaceutical (COLL) Asset Utilization Ratio (2017 - 2026)

Collegium Pharmaceutical's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.48 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 52.63% year-over-year to 0.48 in Q1 2026; TTM through Mar 2026 was 0.48, a 52.63% increase from a year earlier, with the FY2025 full-year figure at 0.47, up 4.5% from the prior year.
• Asset Utilization Ratio rose to 0.48 in Q1 2026 per COLL's latest filing, from 0.48 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.53 in Q2 2024 and bottomed at 0.26 in Q2 2022.
• The 5-year median for Asset Utilization Ratio is 0.45 (2024), against an average of 0.41.
• Across the five-year window, Asset Utilization Ratio sank 45.7% in 2022 and surged 73.3% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.4 in 2022, then rose by 22.11% to 0.49 in 2023, then sank by 39.58% to 0.3 in 2024, then jumped by 62.07% to 0.48 in 2025, then increased by 0.64% to 0.48 in 2026.
• Per Business Quant, the three latest COLL Asset Utilization Ratio figures stand at 0.48 (Q1 2026), 0.48 (Q4 2025), and 0.38 (Q3 2025).